Becker's Healthcare August 15, 2022
Noah Schwartz

Medical technology manufacturing company Boston Scientific has acquired Obsidio, a company that makes technology used in the embolization of blood vessels in the peripheral vasculature.

Embolization is a procedure to reduce blood flow to a tumor and prevent hemorrhaging. Obsidio’s Gel Embolic Material product line is designed to minimize embolization procedure preparation time by delivering the Gel Embolic Material through a catheter, according to the Aug. 15 Boston Scientific news release.

“The Gel Embolic...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Medical Devices, Mergers & Acquisitions / JV, Trends
Related Articles:
Exo adds FDA-cleared AI tools to handheld ultrasound system
FDA spends $1.2M on VR-enabled hub to spur development of at-home care devices
FDA launches initiative to advance home healthcare models, devices
Is Telepathy Possible? Perhaps, Due To New Technology
FDA Proposes Updated Guidance Concerning Cybersecurity of Medical Devices

Share This Article